<![CDATA[MRD Testing Across CLL Treatment Strategies]]>

Monitoring MRD in Multiple Myeloma in Serum by Mass Spectrometry

Conditions : Multiple Myeloma; Minimal Residual Disease Interventions : Diagnostic Test: Mass spectrometry Sponsors : Odense University Hosp

Personalización en el tratamiento de la leucemia linfocítica crónica

Hematólogos destacan que el trabajo en red y los avances en investigación mejoran el diagnóstico y la calidad de vida de los pacientes con e

<![CDATA[Rationale and Timing: The Evolving Role of BCMA-Targeted Therapies in Relapsed/Refractory Multiple Myeloma ]]>

<![CDATA[AI Test Predicts Breast Cancer Recurrence Using Standard Pathology Slides]]>

<![CDATA[BCMA Biology, Mechanisms of Action, and Unmet Needs in Relapsed/Refractory Multiple Myeloma]]>

<![CDATA[From Observation to Treatment: The Role of Caregivers and Overcoming VMAT2 Inhibitor Complexities]]>